EVALUATION OF NADPH OXIDASE 1/4 INHIBITION AS A NOVEL THERAPEUTIC STRATEGY AGAINST CHRONIC PANCREATITIS

$296,997FY2021Defense Health AgencyDOD

University Of Alabama At Birmingham, Birmingham AL

Investigators